Obalon Therapeutics Inc (NASDAQ:OBLN) Director Kim P. Kamdar acquired 13,400 shares of the company’s stock in a transaction dated Wednesday, October 12th. The shares were bought at an average cost of $15.00 per share, with a total value of $201,000.00. The purchase was disclosed in a filing with the SEC, which is accessible through this link.
Obalon Therapeutics Inc (NASDAQ:OBLN) opened at 13.00 on Tuesday. Obalon Therapeutics Inc has a 1-year low of $12.33 and a 1-year high of $15.88. The stock’s 50 day moving average is $14.04 and its 200-day moving average is $14.04.
About Obalon Therapeutics